Class 10 - Live Case from Bristol Heart Centre

James Spratt Professor of Interventional cardiology with a sub-speciality interest in complex PCI, intravascular imaging and CTO. He is widely published within this area and has performed live case demonstrations globally. He has an interest in medical education and is the Founder of Optima Education.

Consultant Interventional Cardiologist and Revascularisation Group Chair at Royal Brompton Hospital, London. His clinical focus is on use of intravascular imaging in complex PCI , CTO and cardiogenic shock. His clinical research interests focus on optical coherence tomography, calcific coronary disease and percutaneous ventricular support. Dr Hill was global co-chief investigator for the DISRUPT CAD III study and has served as UK principal investigator for multiple interventional trials. He has served as a CTO and complex PCI proctor on a global basis and works closely with OPTIMA to focus on the development of OPTIMAL PCI. He is the founding co-director of the Complete Revascularisation (CoRe) meetings held every year in London.

Dr Julian Strange is a consultant interventional cardiologist at Bristol Heart Institute, UK. His specialty and research interests are in coronary disease and include coronary angioplasty, complex PCI and chronic total occlusions (CTO) as well as advanced heart attack and cardiac arrest therapies.

Dr Tom Johnson is an interventional cardiologist and recently appointed Associate Professor at the Bristol Heart Institute & University of Bristol, UK. He is an active member of the EAPCI, currently sitting on the Education & Training, and the Scientific programme committees, with responsibilities for writing the new interventional curriculum and exam. He is a member of the European Bifurcation Club, the ESC ACCA SCAD study group, co-authoring the European position paper, and sits on the UK Societi scientific committee for Kawasaki disease. His academic interests include developing the role of intracoronary imaging in PCI, optimising bifurcation results and platelet pharmacology in acute coronary syndromes. He plays an active role in local, national, and international educational initiatives in developing PCI skills.